| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6067200 | Journal of Allergy and Clinical Immunology | 2011 | 9 Pages |
Abstract
The K+ channel KCa3.1 plays a key role in human fibrocyte migration. Currently available KCa3.1-channel blockers might therefore attenuate tissue fibrosis and remodeling in patients with diseases such as idiopathic pulmonary fibrosis and asthma through the inhibition of fibrocyte recruitment.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Glenn PhD, Shailendra R. PhD, S. Mark PhD, Camille BSc, Ruth PhD, Chris E. PhD, Peter DM,